Internal Medicine, Hematology & Oncology · Fayetteville, GA
NPI
1649228651
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1265 Highway 54 W Ste 4200
Fayetteville, GA, 30214
Phone (678) 829-1060
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.1M
267,603 services
Medicare patients, 2024
789
Average age 75
Drug cost, 2024
$9.0M
3,465 prescriptions
Company payments, 2025
$697
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan C Bender was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 35,525 times for 19 patients. In total Jonathan C Bender billed 267,603 services in 144 codes, and Medicare paid $5.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 35,525 | 19 | $2.21 | $78K |
| J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Office | 31,440 | 13 | $0.73 | $23K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 23,201 | 27 | $42.16 | $978K |
| J0897 Injection, denosumab, 1 mg | Office | 18,360 | 78 | $19.37 | $356K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 14,580 | 11 | $36.88 | $538K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 7,200 | 58 | $14.93 | $107K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,108 | 58 | $0.08 | $178 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 1,910 | 11 | $30.01 | $57K |
| 85025 Blood Count | Office | 1,386 | 514 | $7.57 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 830 | 25 | $0.65 | $542 |
| 99214 Office E&M - Established | Office | 653 | 237 | $89.65 | $59K |
| 96372 Injection Administration | Office | 652 | 150 | $10.19 | $6,644 |
| J9196 Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | Office | 559 | 15 | $5.96 | $3,329 |
| 99213 Office E&M - Established | Office | 548 | 388 | $58.69 | $32K |
| 96413 Chemotherapy Administration | Office | 530 | 120 | $92.27 | $49K |
By year: 2022 $5.2M for 287,622 services; 2023 $5.3M for 260,085 services; 2024 $5.1M for 267,603 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,386 | 514 | $7.57 | $10K |
| 81002 Clinical Chemistry | 85 | 31 | $3.41 | $290 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan C Bender prescribed most often to Medicare patients was Anastrozole, with 370 prescriptions and refills. In total Jonathan C Bender wrote 3,465 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 370 | 984 | 116 | $7,910 |
| Eliquis Apixaban | 157 | 256 | 42 | $148K |
| Ondansetron Odt Ondansetron | 126 | 127 | 77 | $1,828 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 118 | 118 | 30 | $3,841 |
| Prochlorperazine Maleate Generic | 101 | 104 | 64 | $1,568 |
| Xarelto Rivaroxaban | 93 | 184 | 20 | $99K |
| Gabapentin Generic | 89 | 131 | 27 | $1,321 |
| Levothyroxine Sodium Generic | 86 | 173 | 20 | $1,314 |
| Revlimid Lenalidomide | 80 | 80 | Under 11 | $1.3M |
| Oxycodone Hcl Generic | 77 | 79 | 20 | $2,110 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 76 | 76 | 51 | $971 |
| Letrozole Generic | 75 | 188 | 27 | $1,948 |
| Valacyclovir Valacyclovir Hcl | 72 | 144 | 23 | $3,105 |
| Imbruvica Ibrutinib | 70 | 70 | Under 11 | $1.1M |
| Dexamethasone Generic | 67 | 79 | 36 | $1,410 |
Brand drugs: - claims; generic drugs: 2,562 claims; opioid claims: 370.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan C Bender $697 ($697 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $113.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $113 |
| Genzyme Corporation SNY | 3 | $88.39 |
| Daiichi Sankyo Inc. 4568.T | 3 | $68.37 |
| GlaxoSmithKline, LLC. GSK | 3 | $67.72 |
| Merck Sharp & Dohme LLC MRK | 3 | $64.88 |
| Pfizer Inc. PFE | 3 | $61.84 |
| Janssen Biotech, Inc. JNJ | 2 | $44.39 |
| Gilead Sciences, Inc. GILD | 1 | $25.64 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25.39 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $24.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.